Cochrane · systematic review · CD013683

Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery

Amaral, FCF, Baptista-Silva, JCC, Nakano, LCU, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

VascularAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
28
current version
GRADE rated
24
No studies
4
Included studies
NR
No studies 4 · 14.3%Ungraded 0 · 0%Very low 11 · 39.3%Low 13 · 46.4%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Higher‐dose heparin compared to standard‐dose heparin for preventing venous thromboembolism in people undergoing bariatric surgery

Population: people undergoing bariatric surgery
7 questions
OutcomeEffectEvidenceStatus / GRADE
VTE
Higher‐dose heparin vs standard‐dose heparin
RR 0.55 [0.05, 5.99]4 studies · 597 participantsLow
Downgraded: risk of bias, imprecision
Major bleeding
Higher‐dose heparin vs standard‐dose heparin
RR 1.19 [0.48, 2.96]4 studies · 597 participantsLow
Downgraded: risk of bias, imprecision
All‐cause mortality
Higher‐dose heparin vs standard‐dose heparin
no estimate extracted4 studies · 597 participantsLow
Downgraded: imprecision
VTE‐related mortality
Higher‐dose heparin vs standard‐dose heparin
no estimate extracted4 studies · 597 participantsLow
Downgraded: imprecision
PE
Higher‐dose heparin vs standard‐dose heparin
RR 0.37 [0.02, 8.92]2 studies · 310 participantsVery low
Downgraded: risk of bias, imprecision
DVT
Higher‐dose heparin vs standard‐dose heparin
RR 1.1 [0.07, 17.4]4 studies · 597 participantsVery low
Downgraded: risk of bias, imprecision
Adverse events (thrombocytopenia)
Higher‐dose heparin vs standard‐dose heparin
RR 1.1 [0.07, 17.4]2 studies · 310 participantsVery low
Downgraded: risk of bias, imprecision

Heparin compared to pentasaccharide for preventing venous thromboembolism in people undergoing bariatric surgery

Population: people undergoing bariatric surgery
7 questions
OutcomeEffectEvidenceStatus / GRADE
VTE
Heparin vs pentasaccharide
RR 0.83 [0.19, 3.61]1 study · 175 participantsLow
Downgraded: risk of bias, imprecision
Major bleeding
Heparin vs pentasaccharide
RR 1.7 [0.42, 6.92]1 study · 198 participantsVery low
Downgraded: risk of bias, imprecision
All‐cause mortality
Heparin vs pentasaccharide
no estimate extracted1 study · 198 participantsVery low
Downgraded: risk of bias, imprecision
VTE‐related mortality
Heparin vs pentasaccharide
no estimate extracted1 study · 198 participantsVery low
Downgraded: risk of bias, imprecision
PE
Heparin vs pentasaccharide
no estimate extracted1 study · 198 participantsVery low
Downgraded: risk of bias, imprecision
DVT
Heparin vs pentasaccharide
RR 0.83 [0.19, 3.61]1 study · 175 participantsLow
Downgraded: risk of bias, imprecision
Adverse events (thrombocytopenia)
Heparin vs pentasaccharide
RR 0.34 [0.01, 8.25]1 study · 198 participantsVery low
Downgraded: risk of bias, imprecision

Heparin started before compared to after the surgical procedure for preventing venous thromboembolism in people undergoing bariatric surgery

Population: people undergoing bariatric surgery
7 questions
OutcomeEffectEvidenceStatus / GRADE
VTE
Heparin started before vs after the surgical procedure
RR 0.11 [0.01, 2.01]1 study · 100 participantsLow
Downgraded: risk of bias, imprecision
Major bleeding
Heparin started before vs after the surgical procedure
RR 3 [0.13, 71.92]1 study · 100 participantsVery low
Downgraded: risk of bias, imprecision
All‐cause mortality
Heparin started before vs after the surgical procedure
no estimate extracted1 study · 100 participantsVery low
Downgraded: risk of bias, imprecision
VTE‐related mortality
Heparin started before vs after the surgical procedure
no estimate extracted1 study · 100 participantsVery low
Downgraded: risk of bias, imprecision
PE
Heparin started before vs after the surgical procedure
no estimate extractedNRNo studies
DVT
Heparin started before vs after the surgical procedure
RR 0.11 [0.01, 2.01]1 study · 100 participantsLow
Downgraded: risk of bias, imprecision
Adverse events (thrombocytopenia)
Heparin started before vs after the surgical procedure
no estimate extractedNRNo studies

Combined mechanical and pharmacological prophylaxis compared to mechanical prophylaxis alone for preventing venous thromboembolism in people undergoing bariatric surgery

Population: people undergoing bariatric surgery
7 questions
OutcomeEffectEvidenceStatus / GRADE
VTE
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
RR 0.05 [0, 0.89]1 study · 150 participantsLow
Downgraded: imprecision
Major bleeding
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
no estimate extracted1 study · 150 participantsLow
Downgraded: imprecision
All‐cause mortality
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
no estimate extracted1 study · 150 participantsLow
Downgraded: imprecision
VTE‐related mortality
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
no estimate extracted1 study · 150 participantsLow
Downgraded: imprecision
PE
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
no estimate extractedNRNo studies
DVT
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
RR 0.05 [0, 0.89]1 study · 150 participantsLow
Downgraded: imprecision
Adverse events
Combined mechanical and pharmacological prophylaxis vs mechanical prophylaxis alone
no estimate extractedNRNo studies